C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations

Christopher C. Butler*, David Gillespie, Patrick White, Janine Bates, Rachel Lowe, Emma Thomas-Jones, Mandy Wootton, Kerenza Hood, Rhiannon Phillips, Hasse Melbye, Carl Llor, Jochen W. L. Cals, Gurudutt Naik, Nigel Kirby, Micaela Gal, Evgenia Riga, Nick A. Francis

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)111-120
Number of pages10
JournalNew England Journal of Medicine
Volume381
Issue number2
DOIs
Publication statusPublished - 11 Jul 2019

Keywords

  • OBSTRUCTIVE PULMONARY-DISEASE
  • RESPIRATORY-TRACT INFECTION
  • OF-CARE
  • STREPTOCOCCUS-PNEUMONIAE
  • RESISTANCE
  • SUSCEPTIBILITY
  • PREDICTORS
  • BIOMARKERS
  • THERAPY
  • EUROPE

Cite this

Butler, C. C., Gillespie, D., White, P., Bates, J., Lowe, R., Thomas-Jones, E., Wootton, M., Hood, K., Phillips, R., Melbye, H., Llor, C., Cals, J. W. L., Naik, G., Kirby, N., Gal, M., Riga, E., & Francis, N. A. (2019). C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. New England Journal of Medicine, 381(2), 111-120. https://doi.org/10.1056/NEJMoa1803185